[go: up one dir, main page]

ATE291577T1 - Cyanoindol-derivate als inhibitoren der wiederaufnahme von serotonin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen - Google Patents

Cyanoindol-derivate als inhibitoren der wiederaufnahme von serotonin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen

Info

Publication number
ATE291577T1
ATE291577T1 AT00402799T AT00402799T ATE291577T1 AT E291577 T1 ATE291577 T1 AT E291577T1 AT 00402799 T AT00402799 T AT 00402799T AT 00402799 T AT00402799 T AT 00402799T AT E291577 T1 ATE291577 T1 AT E291577T1
Authority
AT
Austria
Prior art keywords
reuppost
cyanoindole
serotonin
inhibitors
derivatives
Prior art date
Application number
AT00402799T
Other languages
English (en)
Inventor
Gilbert Lavielle
Olivier Muller
Mark Millan
Didier Cussac
Anne Dekeyne
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE291577T1 publication Critical patent/ATE291577T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT00402799T 1999-10-12 2000-10-11 Cyanoindol-derivate als inhibitoren der wiederaufnahme von serotonin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen ATE291577T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9912668A FR2799463B1 (fr) 1999-10-12 1999-10-12 Nouveaux composes cyano-indoles inhibiteurs de recapture de serotonine, leur procede de preparation et ces compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ATE291577T1 true ATE291577T1 (de) 2005-04-15

Family

ID=9550799

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00402799T ATE291577T1 (de) 1999-10-12 2000-10-11 Cyanoindol-derivate als inhibitoren der wiederaufnahme von serotonin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen

Country Status (22)

Country Link
US (1) US6492366B1 (de)
EP (1) EP1092715B1 (de)
JP (1) JP3274454B2 (de)
KR (1) KR100470692B1 (de)
CN (1) CN1146568C (de)
AT (1) ATE291577T1 (de)
AU (1) AU774741B2 (de)
BR (1) BR0004764A (de)
CA (1) CA2323703C (de)
DE (1) DE60018869T2 (de)
DK (1) DK1092715T3 (de)
EA (1) EA003831B1 (de)
ES (1) ES2238260T3 (de)
FR (1) FR2799463B1 (de)
HU (1) HUP0003991A2 (de)
MX (1) MXPA00009642A (de)
NO (1) NO321242B1 (de)
NZ (1) NZ507458A (de)
PL (1) PL343148A1 (de)
PT (1) PT1092715E (de)
SI (1) SI1092715T1 (de)
ZA (1) ZA200005625B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693202B1 (en) 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
WO2002085896A1 (en) * 2001-04-24 2002-10-31 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
US7041683B2 (en) 2001-04-24 2006-05-09 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1, 4-benzodiozan
US7276603B2 (en) * 2003-05-02 2007-10-02 Wyeth Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use
WO2005112906A2 (en) * 2004-05-21 2005-12-01 Duke University Method for augmenting the effects of serotonin reuptake inhibitors
EP2629615B1 (de) 2010-10-22 2018-10-10 Duke University Retardformulierungen aus 5-hydroxytryptophan als zusatz für pro-serotonergische therapien

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2043709C (en) * 1990-06-29 2002-01-22 David W. Smith Antimigraine alkoxypyrimidine derivatives
CA2091562C (en) * 1990-10-15 2001-03-27 John Eugene Macor Indole derivatives useful in psychotherapeutics
GB9208161D0 (en) * 1992-04-14 1992-05-27 Pfizer Ltd Indoles
FR2701026B1 (fr) * 1993-02-02 1995-03-31 Adir Nouveaux dérivés de l'indole, de l'indazole et du benzisoxazole, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
IT1271352B (it) * 1993-04-08 1997-05-27 Boehringer Ingelheim Italia Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
ES2079323B1 (es) * 1994-06-21 1996-10-16 Vita Invest Sa Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
WO1996001865A1 (en) * 1994-07-11 1996-01-25 Dsm N.V. Multihydroxy-functional oligophenylene oxide
AR004229A1 (es) * 1995-11-06 1998-11-04 Wyeth Corp Derivados indolalquilo de benzodioxanmetilamina y su uso para preparar medicamentos
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5998462A (en) * 1996-12-16 1999-12-07 Allelix Biopharmaceuticals Inc. 5-alkyl indole compounds

Also Published As

Publication number Publication date
ES2238260T3 (es) 2005-09-01
CA2323703C (fr) 2005-08-16
US6492366B1 (en) 2002-12-10
EA003831B1 (ru) 2003-10-30
CN1146568C (zh) 2004-04-21
NO321242B1 (no) 2006-04-10
DE60018869D1 (de) 2005-04-28
FR2799463A1 (fr) 2001-04-13
BR0004764A (pt) 2001-05-29
JP2001151772A (ja) 2001-06-05
SI1092715T1 (en) 2005-06-30
NZ507458A (en) 2002-03-28
HK1036062A1 (en) 2001-12-21
EA200000929A2 (ru) 2001-04-23
ZA200005625B (en) 2001-05-02
EP1092715A2 (de) 2001-04-18
AU6547900A (en) 2001-04-26
MXPA00009642A (es) 2002-05-23
KR100470692B1 (ko) 2005-03-07
AU774741B2 (en) 2004-07-08
DE60018869T2 (de) 2006-02-02
EA200000929A3 (ru) 2001-06-25
FR2799463B1 (fr) 2004-04-16
DK1092715T3 (da) 2005-07-25
KR20010050984A (ko) 2001-06-25
HUP0003991A2 (en) 2002-06-29
EP1092715A3 (de) 2001-08-08
HU0003991D0 (en) 2000-12-28
CN1296010A (zh) 2001-05-23
PL343148A1 (en) 2001-04-23
NO20005103D0 (no) 2000-10-10
JP3274454B2 (ja) 2002-04-15
NO20005103L (no) 2001-04-17
PT1092715E (pt) 2005-06-30
EP1092715B1 (de) 2005-03-23
CA2323703A1 (fr) 2001-04-12

Similar Documents

Publication Publication Date Title
AR025386A1 (es) Moduladores de los receptores activados del proliferador de peroxisomas
AR016666A1 (es) Derivados de pirimidinona, un procedimiento para su preparacion y una composicion farmaceutica que los contiene
KR860004894A (ko) 벤조옥사졸- 및 벤조티아졸아민 유도체의 제조방법
ATE291577T1 (de) Cyanoindol-derivate als inhibitoren der wiederaufnahme von serotonin, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DK397383D0 (da) 2-nitro-1,1-ethendiaminer, fremgangsmader til fremstilling deraf samt deres anvendelse som laegemidler
DE69519047D1 (de) Benzodioxan Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
ES2162856T3 (es) Derivados de ergolina serotoninergicos.
AR018632A1 (es) Compuestos derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene, proceso para su preparacion.
AR012990A1 (es) Compuestos de benzo(5,6) cicloheptapiridina, composiciones farmaceuticas que los contienen, y el uso de dichos compuestos como inhibidores de laproteina farnesil transferasa.
AR029468A1 (es) Derivados de aminoacidos n-mercaptoacilados, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
ATE215080T1 (de) 1,2-dithiolan derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE60000328D1 (de) Camptothecin Analoge Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
AR026222A1 (es) Compuestos derivados de acido antranilico
ATE216392T1 (de) 7-oxo-2,3,7,14-tetrahydro-1h-benzo(b)pyrano(3,2 h)acridincarboxylatderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE69702955D1 (de) Bis-Imide Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitung
DE60002759D1 (de) 3-imino-1,2-dithiolen derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
IT1213440B (it) 2-ditioalchil-diidropiridine, un metodo per la loro preparazione e composizioni farmaceutiche chele contengono.
MX9703112A (es) Nitro-benzamidas utiles como agentes antiarritmicos.
ES8705879A1 (es) Procedimiento para la obtencion de diversos 4-(7-benzofuril)-2,6-dimetil-1,4-dihidropiridinas-3,5-diesterificadas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1092715

Country of ref document: EP

REN Ceased due to non-payment of the annual fee